Early onset hypertension predicts prolonged progression-free and overall survival in women with mullerian duct adenocarcinomas treated with bevacizumab

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2012-03, Vol.125, p.S29-S30
Main Authors: Christie, C, Ross, E, Slifker, M, Warshal, D, Aikins, J, Burger, R
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Obstetrics and Gynecology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2011.12.066